Stericycle (NASDAQ:SRCL) Releases FY 2024 Earnings Guidance

Stericycle (NASDAQ:SRCL) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 2.200-2.500 for the period, compared to the consensus estimate of 2.330. The company issued revenue guidance of -.

Analysts Set New Price Targets

A number of brokerages have weighed in on SRCL. Royal Bank of Canada reaffirmed an outperform rating and issued a $69.00 price target on shares of Stericycle in a research note on Thursday, March 7th. Wells Fargo & Company boosted their price objective on shares of Stericycle from $40.00 to $48.00 and gave the stock an underweight rating in a research report on Friday, March 1st. StockNews.com lowered shares of Stericycle from a buy rating to a hold rating in a research report on Tuesday, April 2nd. Stifel Nicolaus boosted their price objective on shares of Stericycle from $70.00 to $75.00 and gave the stock a buy rating in a research report on Thursday, February 29th. Finally, Truist Financial boosted their price objective on shares of Stericycle from $50.00 to $57.00 and gave the stock a hold rating in a research report on Thursday, February 29th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Stericycle has an average rating of Hold and a consensus target price of $60.80.

Stericycle Stock Down 0.4 %

SRCL traded down $0.20 during trading on Friday, reaching $46.31. 802,019 shares of the stock were exchanged, compared to its average volume of 467,025. The stock has a market cap of $4.30 billion, a P/E ratio of -192.95, a price-to-earnings-growth ratio of 2.68 and a beta of 1.09. Stericycle has a twelve month low of $37.78 and a twelve month high of $57.06. The stock’s 50 day moving average price is $51.35 and its two-hundred day moving average price is $48.17. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.94 and a current ratio of 0.94.

Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. The business had revenue of $664.90 million for the quarter, compared to the consensus estimate of $676.42 million. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. The firm’s revenue for the quarter was down 2.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.49 earnings per share. Equities analysts expect that Stericycle will post 2.32 EPS for the current year.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.